ARCH Venture Partners XII, LLC

ARCH Venture Partners XII, LLC is listed in filings as Director, 10% Owner at Metsera, Inc.. This profile follows SEC Form 4 activity through Nov 14, 2025, including purchase activity. Recent filings connect the profile to Metsera, Inc. (MTSR), Neumora Therapeutics, Inc. Common Stock (NMRA), and Prime Medicine, Inc. (PRME). The current snapshot covers public activity from Aug 1, 2025 to Nov 14, 2025. Reported amounts are shown as $83 to $10.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.